Respiratory syncytial virus: diagnosis, prevention and management
Respiratory syncytial virus (RSV) is responsible for a large burden of disease globally and can present as a variety of clinical syndromes in children of all ages. Bronchiolitis in infants under 1 year of age is the most common clinical presentation hospitalizing 24.2 per 1000 infants each year in t...
Main Authors: | Rachael Barr, Christopher A. Green, Charles J. Sande, Simon B. Drysdale |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-07-01
|
Series: | Therapeutic Advances in Infectious Disease |
Online Access: | https://doi.org/10.1177/2049936119865798 |
Similar Items
-
Respiratory syncytial virus: diagnosis, prevention and management
by: Barr, R, et al.
Published: (2019) -
Vaccination against respiratory syncytial virus
by: Green, CA, et al.
Published: (2020) -
Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
by: Drysdale, S, et al.
Published: (2020) -
Respiratory syncytial virus: Immunisation and prophylaxis
by: Barr, R, et al.
Published: (2018) -
Airway response to respiratory syncytial virus has incidental antibacterial effects
by: Sande, C, et al.
Published: (2019)